| | | |
Group
| |
|---|
|
Characteristics2
| |
Placebo
|
Low-ARA
|
High-ARA
|
|---|
| | |
(n = 20)
|
(n = 22)
|
(n = 22)
|
|---|
|
Gender (Female)
|
n
|
12
|
13
|
12
|
|
Age
|
y
|
63.1 ± 3.8
|
62.8 ± 4.3
|
62.9 ± 4.2
|
|
BMI
|
kg/m2
|
21.5 ± 2.4
|
22.5 ± 2.0
|
22.5 ± 3.1
|
|
Alcohol consumption
| | | | |
|
Positive
|
n
|
11
|
13
|
9
|
|
Negative
|
n
|
9
|
9
|
13
|
|
Smoking status
| | | | |
|
Positive
|
n
|
4
|
3
|
3
|
|
Negative
|
n
|
16
|
19
|
19
|
|
Exercise
| | | | |
|
Habitual
|
n
|
11
|
15
|
14
|
|
Nonhabitual
|
n
|
9
|
7
|
8
|
|
hs-CRP
|
μg/dL
|
113 ± 98
|
106 ± 153
|
104 ± 116
|
|
PT
|
%
|
91.4 ± 8.5
|
91.4 ± 8.6
|
91.5 ± 6.5
|
|
HbA1c
|
%
|
4.9 ± 0.2
|
4.9 ± 0.3
|
4.9 ± 0.4
|
|
FA composition
| | | | |
|
18:2n-6
|
%
|
18.33 ± 2.64
|
18.91 ± 2.16
|
17.78 ± 2.62
|
|
20:4n-6
|
%
|
8.27 ± 1.26
|
8.61 ± 0.92
|
8.77 ± 1.32
|
|
20:5n-3
|
%
|
2.85 ± 1.30
|
3.17 ± 1.42
|
3.59 ± 2.16
|
|
22:6n-3
|
%
|
7.83 ± 1.42
|
8.10 ± 1.27
|
8.41 ± 2.29
|
- 1Values are means ± SD. No significance among the groups (ANOVA and Tukey-Kramer or Kruskal-Wallis tests).
- 2hs-CRP, high-sensitivity CRP; PT, prothrombin time; HbA1c, hemoglobin A1c; FA, fatty acid; 18:2n-6, linoleic acid; 20:4n-6, arachidonic acid; 20:5n-3, eicosapentaenoic acid; 22:6n-3, docosahexaenoic acid.
